Onera Will Showcase Its Onera hPSG® Solution at the SLEEP 2026 Conference June 14-17, 2026 in Baltimore, MD, USA.
11.6.2026 15:00:00 CEST | Business Wire | Press Release
Onera Health, a leader in transforming sleep medicine, announces that its end-to-end home polysomnography solution, the Onera hPSG® solution, will be prominently featured in multiple scientific presentations at the forthcoming SLEEP 2026 conference. The medtech company will showcase this innovative solution at booth #600 during the largest annual sleep medicine conference, which brings together leading experts and innovators in the field. Furthermore, in anticipation of new CPT codes, Onera Health will host an educational symposium on Scaling PSG for the Next Decade: Expanding Utilization of High-Complexity Home Testingon Monday, June 15.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260611302332/en/
Onera hPSG® – Bringing PSG Home.
“We are excited to see our Onera hPSG® solution highlighted at this important meeting in three different presentations and an educational seminar. Onera hPSG® is positioned to be an integral part of the evolving field of sleep medicine enabling PSG, the gold standard of sleep testing, to be performed in the patient’s home, increasing access and convenience while providing equivalent diagnostic insights,” states Ruben de Francisco, Founder and CEO of Onera Health.
"Onera hPSG® - Bringing PSG Home"
At the Onera sponsored educational seminar titled “Scaling PSG for the Next Decade: Expanding Utilization of High-Complexity Home Testing”, experts from leading institutions will present and discuss validation results, insights from real-world implementation, and the clinical and practice implications of home PSG testing. Presentations will include:
- “Mild or Missed? Women Deserve Better Sleep Diagnostics” presented by Audrey Wells, MD, Chief Medical Officer at SLIIIP.com.
- “Bringing Comprehensive Sleep Diagnostics to the Home: Real World Experience from Kaiser Permanente”, presented by Anupamjeet Sekhon, MD, Kaiser Permanente Fontana Medical Center.
“Home polysomnography addresses significant access challenges for patients who would benefit from PSG testing. These challenges are caused by the shortage of in-laboratory beds, technicians, and sleep physicians and have led to escalating costs and delayed diagnosis and treatment for many patients suffering from sleep disorders. We are confident this symposium will present valuable information and spark insightful conversations amongst the panelists and participants regarding how hPSG can enhance patient care pathways and be a potential solution to unmet needs in sleep diagnostics and care,” explains de Francisco.
Clinical data related to the Onera hPSG® solution will also be presented in three poster presentations this year. Details of the presentations are as follows:
A Real-World Analysis of Patient-Applied, Home Polysomnography Use Across US and European Settings
Dimitrov T, Stockhoff M, Coughlin S, Schneider H, Velten N
Poster Session P-17 on Monday, June 15, 2026 [ID 1187, Board 394]
Home vs. Lab Polysomnography with a Patch-based System: Longer, More Efficient Sleep at Home Without Respiratory Trade-offs
Schobel C, Viniol C, Galetke W, Woehrle H, Nilius G, Randerath W, Schneider H
Poster Session P-40 on Tuesday, June 16, 2026 [ID 1213, Board 403]
Real-World Validation of Automated Scoring of Home Polysomnography Data
Zimeo Morais G, Meulenbrugge E, Dimitrov T, Honer N, Schneider H
Poster Session P-41 on Tuesday, June 16, 2026 [ID 1455, Board 449]
For more information on the educational event and presentations, please review the SLEEP 2026 agenda at SLEEP Annual Meeting | Program.
About Onera Health
Onera Health is leading the way in transforming sleep medicine by delivering the gold standard of sleep testing, polysomnography (PSG), directly to where the patient sleeps comfortably, in their own home.
The Onera hPSG® solution is expanding access to comprehensive sleep diagnostics for millions of people who remain undiagnosed or undertreated by breaking down long-standing barriers such as limited lab capacity, geographic access, and operational complexity. Through its integrated diagnostic technology, clinical services, and digital platform, Onera hPSG® empowers clinicians with comprehensive, actionable insights while helping healthcare systems deliver more efficient, scalable care.
With commercial operations in the United States and Europe, Onera Health is at the forefront of advancing global sleep health and transforming how sleep disorders are detected, identified, and managed. For more information, visit onerahealth.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260611302332/en/
Contacts
For additional information or media inquiries, please contact:
Swea Ann Hagenhoff
Sr. Branding and Communications Specialist
Onera Health
media@onerahealth.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Garvan Institute of Medical Research Joins Parse Biosciences’ Certified Service Provider Network15.7.2026 22:00:00 CEST | Press Release
Parse Biosciences, a QIAGEN company, and the leader in scalable and accessible single cell sequencing, today announced that the Genomics Platform Core Facility within the Garvan Institute of Medical Research has joined its Certified Service Provider (CSP) Program. The partnership broadens access to high-quality, scalable single cell sequencing across Australia, the wider Asia-Pacific region, and beyond. Garvan is one of Australia's preeminent medical research institutions, with the Genomics Platform having deep experience in cell sorting, capture, and sequencing. As a Certified Service Provider, Garvan will offer Parse's Evercode WT kits to researchers across the region. "We see a growing number of requests for Parse projects and find the technology easy to implement and run, generating great data," said Chris O'Keeffe, Cellular Genomics Lead at the Garvan Institute. "Garvan is one of the most respected biomedical research institutions in the world, and we're honored to welcome them to
Grafana Labs Named a Leader in 2026 Gartner® Magic Quadrant™ for Observability Platforms and Positioned Furthest in Completeness of Vision15.7.2026 20:21:00 CEST | Press Release
Grafana Labs, the company behind the open observability cloud, today announced it has been named a Leader in the Gartner® Magic Quadrant™ for Observability Platforms for the third consecutive year, and positioned furthest on the Completeness of Vision axis for the second year running. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715814984/en/ 2026 Gartner® Magic Quadrant™ for Observability Platforms We believe this placement reflects where the market is headed: toward open, composable observability that helps teams in the AI era understand systems that are increasingly complex and agentic, and rapidly scaling thanks to AI-assisted engineering. A Platform Built for the AI Era According to Grafana Labs’ 2026 Observability Survey, operational complexity and overhead are now the top observability challenge, even as adoption of managed observability continues to climb, with half of organizations now using managed observabili
Spectro Cloud Raises $100 Million Series D to Help Customers Move AI Infrastructure Into Production Across Enterprise, Public Sector, Neocloud and Sovereign Cloud Environments15.7.2026 18:20:00 CEST | Press Release
Spectro Cloud, a leading provider of AI infrastructure management software, today announced it has raised more than $100 million in an oversubscribed Series D funding round led by Growth Equity at Goldman Sachs Alternatives, with strategic participation from AMD Ventures, Ericsson, LG Technology Ventures, and Maximus. The new funding brings Spectro Cloud’s total capital raised to $260 million and will accelerate the company’s mission to help enterprises, public sector organizations, neoclouds and sovereign clouds build and operate production AI infrastructure with greater control over cost, security and governance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715551858/en/ Spectro Cloud raises $100 million Series D funding round to accelerate global adoption of production AI infrastructure. Learn more at spectrocloud.com. Organizations are spending billions on AI silicon and compute capacity. But silicon alone does not
K-Beauty Goes Global: Sales Surge 53% as Korean Innovation Reshapes Beauty Growth15.7.2026 16:00:00 CEST | Press Release
NIQ (NYSE: NIQ), a global leader in consumer intelligence, today released new findings showing K-Beauty has become a rapidly growing global beauty segment, with value sales up 53% year-over-year and 131% over the past two years. The data points to a broader shift in beauty growth, as regional innovation, social commerce and digitally driven consumer demand increasingly shape what scales globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715867578/en/ K-Beauty accelerates across global markets In its latest report, K-Beauty Goes Global, NIQ shows how Korean beauty is reshaping consumer expectations, accelerating innovation cycles and redefining competitive dynamics across the global beauty market. What began as a culturally driven trend now offers a broader signal about the future of beauty: regional trends are increasingly driving global opportunity, and brands need timely intelligence to know which signals will sca
Viz.ai to Support the MINUTE Trial, a Landmark Multicenter Study Evaluating the SCUBA Technique for the Treatment of Intracerebral Hemorrhage15.7.2026 15:00:00 CEST | Press Release
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced its support for the Minimally Invasive Neurosurgery Trial for Ultra-early Treatment (MINUTE) Trial, a prospective, multicenter, randomized study evaluating whether the SCUBA technique, an endoscopic, catheter-based approach for ultra-early evacuation of basal ganglia intracerebral hemorrhage (BGH), is a promising alternative to standard medical management to potentially improve functional patient outcomes. The study aims to initiate both randomization and surgical intervention within 120 minutes of key clinical time points, reflecting the urgent nature of intracerebral hemorrhage care. Participating sites will have the ability to leverage the Viz Neuro Suite platform, including Viz ICH and Viz ICH Plus, to support rapid identification, triage, and care coordination for potentially eligible patients across participating centers. Viz Neuro Suite combines AI-powered imaging analysis with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom